A Phase II Study of a Dose-Density Regimen With Fluorouracil, Epirubicin, and Cyclophosphamide on Days 1 and 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer

BACKGROUND. Recent evidence shows that use of anthracycline and taxane adjuvant chemotherapy and dose-dense regimens, consisting of more frequent administration of the drugs, have improved outcomes for breast cancer patients. In this study, we evaluated administration of an epirubicin-based regimen...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncologist
Autors principals: Pietri, Elisabetta, Andreis, Daniele, Fabbri, Francesca, Menna, Cecilia, Schirone, Alessio, Kopf, Barbara, Rocca, Andrea, Amadori, Dino, De Giorgi, Ugo
Format: Artigo
Idioma:Inglês
Publicat: AlphaMed Press 2015
Matèries:
Clinical Trial Results
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4350798/
https://ncbi.nlm.nih.gov/pubmed/25637379
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0326
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars